Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-812 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70571 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
filingDate |
2002-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2004-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a807882ee32d6ef9ff45562a75f450c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbacfc02df199d7904a1c7b1e90077d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb8c2887d794c2fd3a41a6364142b06f |
publicationDate |
2004-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6835548-B2 |
titleOfInvention |
Isoforms of mouse serotonin 5-HT2c receptor |
abstract |
The invention includes mouse serotonin 5-HT2c receptor isoforms having amino acid replacements at one or more positions of the natural mouse serotonin 5-HT2c receptor polypeptide sequence, specifically at one or more of positions 157, 159 and 161. The polypeptides are useful for identifying ligands which bind with the serotonin 5-HT2c receptor and modulators of the serotonin 5-HT2c, and for identifying drugs with affinity for 5-HT2 receptors which are used to treat schizophrenia, Parkinsonism, and anxiety disorders. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7333554-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9422229-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008156707-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8586634-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010305212-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002186713-A1 |
priorityDate |
1999-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |